Preclinical study of the systemic toxicity and pharmacokinetics of 5-iodo-2-deoxypyrimidinone-2'-deoxyribose as a radiosensitizing prodrug in two, non-rodent animal species: implications for phase I study design.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples